|
1
|
Levy D, Anderson KM, Savage DD, Kannel WB,
Christiansen JC and Castelli WP: Echocardiographically detected
left ventricular hypertrophy: Prevalence and risk factors. The
Framingham Heart Study. Ann Intern Med. 108:7–13. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schirmer H, Lunde P and Rasmussen K:
Prevalence of left ventricular hypertrophy in a general population;
The Tromsø Study. Eur Heart J. 20:429–438. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cuspidi C, Sala C, Negri F, Mancia G and
Morganti A; Italian Society of Hypertension, : Prevalence of
left-ventricular hypertrophy in hypertension: An updated review of
echocardiographic studies. J Hum Hypertens. 26:343–349. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Eguchi K, Boden-Albala B, Jin Z, Rundek T,
Sacco RL, Homma S and Di Tullio MR: Association between diabetes
mellitus and left ventricular hypertrophy in a multiethnic
population. Am J Cardiol. 101:1787–1791. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Levy D, Garrison RJ, Savage DD, Kannel WB
and Castelli WP: Prognostic implications of echocardiographically
determined left ventricular mass in the Framingham Heart Study. N
Engl J Med. 322:1561–1566. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Haider AW, Larson MG, Benjamin EJ and Levy
D: Increased left ventricular mass and hypertrophy are associated
with increased risk for sudden death. J Am Coll Cardiol.
32:1454–1459. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
McKee PA, Castelli WP, McNamara PM and
Kannel WB: The natural history of congestive heart failure: The
Framingham study. N Engl J Med. 285:1441–1446. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Okin PM, Devereux RB, Jern S, Kjeldsen SE,
Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM,
et al LIFE Study Investigators, : Regression of
electrocardiographic left ventricular hypertrophy during
antihypertensive treatment and the prediction of major
cardiovascular events. JAMA. 292:2343–2349. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hinderliter A, Sherwood A, Gullette ECD,
Babyak M, Waugh R, Georgiades A and Blumenthal JA: Reduction of
left ventricular hypertrophy after exercise and weight loss in
overweight patients with mild hypertension. Arch Intern Med.
162:1333–1339. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Verdecchia P, Angeli F, Borgioni C,
Gattobigio R, de Simone G, Devereux RB and Porcellati C: Changes in
cardiovascular risk by reduction of left ventricular mass in
hypertension: A meta-analysis. Am J Hypertens. 16:895–899. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sobenin IA, Andrianova IV, Demidova ON,
Gorchakova T and Orekhov AN: Lipid-lowering effects of
time-released garlic powder tablets in double-blinded
placebo-controlled randomized study. J Atheroscler Thromb.
15:334–338. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ried K, Frank OR and Stocks NP: Aged
garlic extract reduces blood pressure in hypertensives: A
dose-response trial. Eur J Clin Nutr. 67:64–70. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dhawan V and Jain S: Garlic
supplementation prevents oxidative DNA damage in essential
hypertension. Mol Cell Biochem. 275:85–94. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Budoff MJ, Ahmadi N, Gul KM, Liu ST,
Flores FR, Tiano J, Takasu J, Miller E and Tsimikas S: Aged garlic
extract supplemented with B vitamins, folic acid and L-arginine
retards the progression of subclinical atherosclerosis: A
randomized clinical trial. Prev Med. 49:101–107. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Budoff MJ, Takasu J, Flores FR, Niihara Y,
Lu B, Lau BH, Rosen RT and Amagase H: Inhibiting progression of
coronary calcification using Aged Garlic Extract in patients
receiving statin therapy: A preliminary study. Prev Med.
39:985–991. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nasir K, Katz R, Mao S, Takasu J, Bomma C,
Lima JA, Bluemke DA, Kronmal R, Carr JJ and Budoff MJ: Comparison
of left ventricular size by computed tomography with magnetic
resonance imaging measures of left ventricle mass and volumes: The
multi-ethnic study of atherosclerosis. J Cardiovasc Comput Tomogr.
2:141–148. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Walker JR, Abadi S, Solomonica A, Mutlak
D, Aronson D, Agmon Y and Lessick J: Left-sided cardiac chamber
evaluation using single-phase mid-diastolic coronary computed
tomography angiography: Derivation of normal values and comparison
with conventional end-diastolic and end-systolic phases. Eur
Radiol. 26:3626–3634. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Varshney R and Budoff MJ: Garlic and Heart
Disease. J Nutr. 146:416S–421S. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Larijani VN, Ahmadi N, Zeb I, Khan F,
Flores F and Budoff M: Beneficial effects of aged garlic extract
and coenzyme Q10 on vascular elasticity and endothelial function:
The FAITH randomized clinical trial. Nutrition. 29:71–75. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zeb I, Ahmadi N, Nasir K, Kadakia J,
Larijani VN, Flores F, Li D and Budoff MJ: Aged garlic extract and
coenzyme Q10 have favorable effect on inflammatory markers and
coronary atherosclerosis progression: A randomized clinical trial.
J Cardiovasc Dis Res. 3:185–190. 2012. View Article : Google Scholar : PubMed/NCBI
|
